By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

  • Home
  • >
  • Latest Headlines
  • >
  • LAMA2 Muscular Dystrophy Drug Candidate TXA127 Is Granted Orphan Drug Status – Muscular Dystrophy News

LAMA2 Muscular Dystrophy Drug Candidate TXA127 Is Granted Orphan Drug Status – Muscular Dystrophy News

Thursday, 18 February, 2016

LAMA2 Muscular Dystrophy Drug Candidate TXA127 Is Granted Orphan Drug Status – Muscular Dystrophy News

Tarix Orphan LLC recently announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation to TXA127, the company's lead candidate for the treatment of laminin-deficient congenital muscular dystrophy (LAMA2 MD).

Read More

Source:LAMA2 Muscular Dystrophy Drug Candidate TXA127 Is Granted Orphan Drug Status - Muscular Dystrophy News

Categories :
  • Latest Headlines
  • Muscular Dystrophy
  • Uncategorized
Socials :

Recent posts

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Our Awards and Partners

Copyright © 2022 All rights reserved